| Field | Specification |
|---|---|
| Mfr No | |
| Alternative Names | OLFML2A; Olfactomedin-like protein 2A; Photomedin-1 |
| Clonality | |
| Concentration | |
| Gene ID | |
| Host | |
| Immunogen | The antiserum was produced against synthesized peptide derived from human OLFML2A. AA range:311-360 |
| Isotype | |
| Product Type | |
| Reactivity | |
| Storage |
Product Overview
Polyclonal Primary AntibodyAnti-Photomedin-1 rabbit pAb antibody (, -derived) validated for use in multiple research applications. Targets Photomedin-1 rabbit pAb in validated species samples.
Antibody Specifications
Scientific Background
PTM:May be cleaved at Lys-295 after secretion.,PTM:O-glycosylated but not N-glycosylated.,similarity:Contains 1 olfactomedin-like domain.,subunit:Homodimer. Binds to heparin and chondroitin sulfate E.,
Subcellular Location: Secreted . Localizes to the podocyte major processes. Colocalized with the major process protein VIM throughout podocyte development. .
Safety & Handling
Related Products
Explore our complete catalog of antibodies, ELISA kits, and life science research reagents at BioHippo.
Store at -20°C for long-term storage. For short-term use (up to 4 weeks), store at 4°C. Avoid repeated freeze-thaw cycles. Centrifuge briefly before opening if condensation is visible.
Customization & Add-ons: Can’t find the antibody you need—or require a custom format for your assay? We can help you source the best match or support custom antibody solutions for diverse research needs, including species and isotype selection, conjugations and labeling (e.g., HRP/AP, biotin, fluorophores), purification grade options (Protein A/G, affinity purified), formulation preferences (buffer selection, carrier-free, glycerol-free), custom concentrations and aliquoting, low-endotoxin options for cell-based work, and application-focused QC/validation support (project dependent). Click Talk to a Scientist to submit a request, email us at support@biohippo.com, or explore our Research Services for additional support—our team will follow up with feasibility details and next steps.